The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer
about
Notch1 regulates the expression of the multidrug resistance gene ABCC1/MRP1 in cultured cancer cellsRelationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significanceMultidrug resistance and cancer stem cells in neuroblastoma and hepatoblastomaChemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy.Interaction of oxazaphosphorines with multidrug resistance-associated protein 4 (MRP4).ABCC11/MRP8 Expression in the Gastrointestinal Tract and a Novel Role forĀ Pepsinogen Secretion.Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.Clinical relevance of P-glycoprotein in drug therapy.Improving cancer chemotherapy with modulators of ABC drug transporters.Epitope mapping of monoclonal antibodies specific for the 190-kDa multidrug resistance protein (MRP).Metabolism and transport of oxazaphosphorines and the clinical implications.Virtual screening of ABCC1 transporter nucleotidebinding domains as a therapeutic target in multidrug resistant cancer.Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins.Application of an original RT-PCR-ELISA multiplex assay for MDR1 and MRP, along with p53 determination in node-positive breast cancer patientsPortrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1).Cancer stem cells and chemoresistance: The smartest survives the raidA molecular understanding of ATP-dependent solute transport by multidrug resistance-associated protein MRP1.Mathematical models of breast and ovarian cancers.Expression of multidrug resistance-associated protein1,P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection.A network-assisted co-clustering algorithm to discover cancer subtypes based on gene expressionImportance of ABCC1 for cancer therapy and prognosis.The molecular mechanisms underlying the therapeutic resistance of cancer stem cells.Mechanisms and therapeutic potential of inhibiting drug efflux transporters.Deregulation of splicing factors and breast cancer development.MRP1 and its role in anticancer drug resistance.Effect of CD38 on the multidrug resistance of human chronic myelogenous leukemia K562 cells to doxorubicin.Nutrient restriction of glucose or serum results in similar proteomic expression changes in 3D colon cancer cell cultures.Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression.Functional importance of polar and charged amino acid residues in transmembrane helix 14 of multidrug resistance protein 1 (MRP1/ABCC1): identification of an aspartate residue critical for conversion from a high to low affinity substrate binding staIssues in experimental design and endpoint analysis in the study of experimental cytotoxic agents in vivo in breast cancer and other models.Multidrug resistance in breast cancer: from in vitro models to clinical studies.Expression of multidrug resistance-related transporters in human breast carcinoma.Investigation of MRP-1 protein and MDR-1 P-glycoprotein expression in invasive breast cancer: a prognostic study.
P2860
Q24614785-AE1FE756-41C5-43EF-8DCA-588BA78E7835Q24813854-70E7357E-7CFC-4DFE-AC01-66774DA47C97Q26822652-9C86E4D7-0292-4617-8CCC-F870EBC57FC2Q30403036-F334ABEF-EE0A-4706-AA52-FD6D397D6129Q33954656-D5EB84F4-7523-4315-903D-C70487ACAA6DQ34184465-197A61F1-6A59-4F3B-A5F4-8A1ABAD9022DQ34204238-27BDE20B-0043-486F-B57E-29F025348657Q35620664-28F8AB09-B1A2-40F5-B2C7-4DB95A90D45FQ36108251-DECE93A3-94D2-42DE-9229-5B04F568C5AEQ36115145-E4BD0847-164B-4036-B204-1AD1BF937E60Q36360811-F96A9B42-A44B-4B15-B62F-7029D6C3BFB0Q36370652-F9F75754-9743-4A29-A882-C7C4157F50FDQ36525551-D37EC14A-8AC4-4878-A315-40073A2D708BQ36620717-F8D8FDE6-32E4-4C66-89F5-97D4C288FDABQ36691571-EA72125E-F303-40E0-9474-9D0B863F1CB8Q36730432-8BCD6132-02C0-4EAC-84C7-FB81725DF99FQ36733893-E6C9C335-49A5-48AB-A6D9-27FD1E14D12CQ37014152-EACA3344-2CC0-42D9-8C72-7D297EAD15B1Q37352734-33E8B5A3-359C-41E0-BCEE-E6BD0F0956AAQ37563126-E52ADD7B-1CAD-4CD1-A8A8-56B4F6C9622CQ38199535-F6380B08-5061-4726-B128-8CB793A7C4FCQ38287226-4C1E9F65-7090-4585-BFCD-A888A7584F5DQ38388828-24FF9AB0-20B0-445B-B4DC-48E2EA047963Q38463397-07165738-177A-4519-BE6B-96585D616145Q38626237-20634634-F15B-4A66-A322-6CC1ED595E40Q38721759-E1C57FB0-35C0-4732-9F7E-D6AD9D19DEBEQ38730154-0781D262-4BD0-4AA8-8961-8FA10FA7C89AQ38837269-AB25BB42-9AA9-400F-9989-EA0192A18464Q40637908-7BB514A6-6975-41BA-A2B2-5F93242F045CQ41710325-0E56E30F-8CB7-468B-94FE-CA28D85E94E7Q42695791-5DDA8122-A238-4812-B424-4834079C2AAAQ43603049-06403058-53AB-4E89-B99E-261B6CE3A9C3Q53886204-F304AFA7-CA4F-4229-ABB9-9B5689154D81
P2860
The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer
description
1997 nĆ® lÅ«n-bĆ»n
@nan
1997幓ć®č«ę
@ja
1997幓å¦ęÆęē«
@wuu
1997幓å¦ęÆęē«
@zh-cn
1997幓å¦ęÆęē«
@zh-hans
1997幓å¦ęÆęē«
@zh-my
1997幓å¦ęÆęē«
@zh-sg
1997幓åøč”ęē«
@yue
1997幓åøč”ęē«
@zh
1997幓åøč”ęē«
@zh-hant
name
The prognostic significance of ...... (MRP) in primary breast cancer
@ast
The prognostic significance of ...... (MRP) in primary breast cancer
@en
type
label
The prognostic significance of ...... (MRP) in primary breast cancer
@ast
The prognostic significance of ...... (MRP) in primary breast cancer
@en
prefLabel
The prognostic significance of ...... (MRP) in primary breast cancer
@ast
The prognostic significance of ...... (MRP) in primary breast cancer
@en
P2093
P2860
P356
P1476
The prognostic significance of ...... (MRP) in primary breast cancer
@en
P2093
Brutel de la Riviere G
Foekens JA
Henzen-Logmans SC
Scheper RJ
van Wingerden KE
P2860
P2888
P304
P356
10.1038/BJC.1997.414
P407
P577
1997-01-01T00:00:00Z